Find A Portfolio/Ticker
Comparison Box
MyPlanIQ
401k Investor
JOLIET ONCOLOGY HEMATOLOGY ASSOCIATES LTD. PROFIT SHARING/401K PLAN
JOLIET ONCOLOGY HEMATOLOGY ASSOCIATES LTD. PROFIT SHARING/401K PLAN Asset Allocation Composite Moderate
JOLIET ONCOLOGY HEMATOLOGY ASSOCIATES LTD. PROFIT SHARING/401K PLAN Asset Allocation Composite Moderate
live (public) 0.58% February 28
Delayed
Holdings (As of 10/31/2024)
sign up and login first and then customize a new portfolio for the latest current holdings
| Asset | Fund in this portfolio | Price change* | Original Fund Description | Percentage |
|---|---|---|---|---|
| General Bond | IIBAX (VOYA INTERMEDIATE BOND FUND CLASS A) | 0.0% | Voya Intermediate Bond Fund R6 | 39.34% |
| US Equity | TBCIX (T. ROWE PRICE BLUE CHIP GROWTH FUND INC. T. ROWE PRICE BLUE CHIP GROWTH FUND-I CLASS) | 2.49% | T.Rowe Price Blue Chip Growth I | 10.83% |
| US Equity | VIGAX (VANGUARD GROWTH INDEX FUND ADMIRAL SHARES) | 2.77% | Vanguard Growth Index Adm | 10.80% |
| CASH | CASH (CASH) | 0.0% | CASH | 0.04% |
| Real Estate | DFREX (DFA REAL ESTATE SECURITIES PORTFOLIO DFA REAL ESTATE SECURITIES PORTFOLIO - INSTITUTIONAL CLASS) | 1.77% | DFA Real Estate Securities Portfolio - Inst Class | 9.86% |
| Emerging Market Equity | DFEVX (EMERGING MARKETS VALUE PORTFOLIO EMERGING MARKETS VALUE PORTFOLIO - INSTITUTIONAL CLASS) | 0.44% | DFA Emerging Markets Value Portfolio - Inst Class | 9.42% |
| International Equity | DISVX (DFA INTERNATIONAL SMALL CAP VALUE PORTFOLIO DFA INTERNATIONAL SMALL CAP VALUE PORTFOLIO - INSTITUTIONAL CLASS) | 0.61% | DFA International Small Cap Value Portfolio - Inst Class | 9.75% |
| International Equity | RNPGX (NEW PERSPECTIVE FUND CLASS R-6) | 1.60% | American Funds New Perspective R6 | 9.96% |
* Day change on 10/31/2024.
Previous
Beta
Performance (As of 02/28/2025)
Since 12/31/2000
| Name | YTD* Return |
1Yr AR** |
3Yr AR** |
5Yr AR** |
10Yr AR** |
15Yr AR** |
|---|---|---|---|---|---|---|
| JOLIET ONCOLOGY HEMATOLOGY ASSOCIATES LTD. PROFIT SHARING/401K PLAN Asset Allocation Composite Moderate | 4.3% | 18.6% | 2.1% | 6.2% | 6.4% | 7.1% |
| VFINX (Vanguard (S&P 500) Index) | 7.7% | 14.0% | 20.1% | 16.2% | 13.5% | 14.6% |
| VBINX (Vanguard Balance (60% stocks/40% bonds) | 5.6% | 9.4% | 12.3% | 8.7% | 8.4% | 9.4% |
* YTD: Year to Date
** AR: Annualized Return
** portfolio AR is delayed
| Last 1 Week* | YTD*(2025) | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 15 Yr | 20 Yr | 20 Yr | Since 01/02/2001 |
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return(%) | 1.2 | 4.3 | 18.6 | 2.1 | 6.2 | 6.4 | 7.1 | 7.4 | 8.1 | 8.3 | 9.2 | 9.1 | 8.3 | -15.7 | 13.8 | 13.5 | 16.9 | -2.7 | 11.3 | 10.1 | -0.4 | 7.9 | 11.9 | 10.8 | 1.7 | 12.6 | 16.4 | 8.5 | 5.6 | 16.0 | 9.1 | 15.1 | 25.5 | 14.0 | 6.6 |
| Sharpe Ratio | NA | 0.29 | 0.41 | -0.2 | 0.44 | 0.58 | NA | NA | NA | NA | 0.98 | 0.32 | 0.5 | -1.9 | 1.54 | 1.64 | 2.68 | -0.47 | 2.31 | 1.63 | -0.07 | 1.29 | 1.62 | 1.64 | 0.12 | 1.24 | 1.49 | 0.92 | 0.27 | 1.77 | 1.01 | 1.75 | 3.88 | 2.21 | 0.65 |
| Draw Down(%) | NA | 2.1 | 6.4 | 15.3 | 18.4 | 18.4 | NA | NA | NA | NA | 18.4 | 5.2 | 8.5 | 16.3 | 3.5 | 8.8 | 2.3 | 10.2 | 2.4 | 4.4 | 6.9 | 4.4 | 6.9 | 5.0 | 11.6 | 7.7 | 5.3 | 4.9 | 6.5 | 7.2 | 4.5 | 9.1 | 3.1 | 3.5 | 6.0 |
| Standard Deviation(%) | NA | 7.5 | 7.8 | 8.3 | 8.3 | 7.5 | NA | NA | NA | NA | 8.0 | 7.9 | 8.0 | 9.0 | 8.9 | 8.1 | 5.8 | 8.4 | 4.6 | 6.1 | 7.0 | 6.1 | 7.3 | 6.6 | 13.6 | 10.1 | 11.0 | 8.2 | 9.8 | 7.2 | 6.8 | 8.1 | 6.4 | 5.8 | 6.6 |
| Treynor Ratio | NA | 0.04 | 0.06 | -0.04 | 0.15 | 0.15 | NA | NA | NA | NA | 0.38 | 0.05 | 0.08 | -0.61 | 0.23 | 1.15 | 0.4 | -0.09 | 0.2 | 0.49 | -0.01 | 0.16 | 0.2 | 0.22 | 0.03 | 0.32 | 1.54 | -2.1 | 0.05 | 0.21 | 0.12 | 0.25 | 3.58 | -1.04 | -0.57 |
| Alpha | NA | 0.04 | -0.01 | -0.02 | 0.0 | 0.01 | NA | NA | NA | NA | 0.03 | -0.02 | -0.02 | -0.05 | -0.01 | 0.04 | 0.02 | 0.0 | 0.0 | 0.03 | 0.0 | 0.01 | -0.02 | 0.02 | 0.0 | 0.03 | 0.05 | 0.02 | 0.01 | 0.02 | 0.02 | 0.03 | 0.08 | 0.04 | 0.01 |
| Beta | NA | 0.5 | 0.52 | 0.37 | 0.25 | 0.29 | NA | NA | NA | NA | 0.2 | 0.54 | 0.52 | 0.28 | 0.59 | 0.11 | 0.39 | 0.47 | 0.54 | 0.2 | 0.33 | 0.49 | 0.6 | 0.48 | 0.56 | 0.39 | 0.11 | -0.04 | 0.57 | 0.61 | 0.56 | 0.57 | 0.07 | -0.12 | -0.08 |
| RSquared | NA | 0.8 | 0.73 | 0.6 | 0.41 | 0.47 | NA | NA | NA | NA | 0.24 | 0.73 | 0.73 | 0.58 | 0.75 | 0.24 | 0.71 | 0.89 | 0.6 | 0.19 | 0.55 | 0.85 | 0.83 | 0.89 | 0.93 | 0.48 | 0.07 | 0.03 | 0.86 | 0.73 | 0.72 | 0.61 | 0.03 | 0.31 | 0.06 |
| Sortino Ratio | NA | 0.43 | 0.55 | -0.27 | 0.62 | 0.79 | NA | NA | NA | NA | 1.38 | 0.43 | 0.73 | -2.34 | 2.25 | 2.28 | 3.97 | -0.61 | 3.62 | 2.27 | -0.09 | 1.87 | 2.29 | 2.52 | 0.16 | 1.78 | 2.23 | 1.35 | 0.36 | 2.73 | 1.48 | 2.46 | 5.96 | 3.18 | 0.89 |
| Yield(%) | N/A | N/A | 2.5 | 3.1 | 4.0 | 4.3 | 5.9 | 5.9 | 9.0 | 9.0 | 4.18 | 2.8 | 3.4 | 3.6 | 4.7 | 2.9 | 2.1 | 3.5 | 3.8 | 4.0 | 2.0 | 3.1 | 4.0 | 4.5 | 2.9 | 3.4 | 3.3 | 4.8 | 6.3 | 6.5 | 4.1 | 3.9 | 3.9 | 9.3 | 5.4 |
| Dividend Growth(%) | N/A | N/A | -18.5 | 14.5 | 59.5 | 71.1 | N/A | N/A | N/A | N/A | N/A | -12.7 | -19.8 | -12.0 | 81.4 | 62.1 | -43.2 | 3.6 | 6.0 | 97.2 | -30.7 | -13.4 | -0.3 | 59.0 | -6.3 | 23.9 | -27.2 | -19.2 | 11.3 | 75.7 | 19.7 | 27.0 | -52.0 | 81.8 | N/A |
*: NOT annualized;YTD: Year to Date
**Inception: starting from 12/31/2000
Portfolio Description
The risk profile of this portfolio is 40%. The total allocation of the fixed income asset should be at least 40%.
The portfolio’s stock (risk asset) allocation can be dynamically reduced when stock or risk asset markets are in a downtrend.
This portfolio belongs to JOLIET ONCOLOGY HEMATOLOGY ASSOCIATES LTD. PROFIT SHARING/401K PLAN.
Register for FREE
No Credit Card Required
Or Start FREE 30-day trial now >>
Or Start FREE 30-day trial now >>